TSLA
Tesla
-- 355.840 NVDA
NVIDIA
-- 138.850 INTC
Intel
-- 23.600 NBIS
NEBIUS
-- 44.490 PLTR
Palantir
-- 119.160 
News
$Accuray (ARAY.US)$ Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution
8 MINUTES AGO, 5:30 PM EDT
VIA PR NEWSWIRE
The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments
MADISON, Wis., Sept. 10, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Gifu Prefectural General Medical Center is setting a new standard in cancer care in Japan as the first hospital in the country to treat patients with surface-guided radiation therapy (SGRT) using the company's Radixact® Radiation Delivery System and VitalHold™* package. SGRT is designed to help medical care teams to effectively position the patient and confidently monitor the accuracy of that positioning throughout treatment. The ability to confidently monitor also enables the deep inspiration breath hold (DIBH) technique, which is often used in left breast cancer treatment to help protect the heart from radiation.
During treatment with SGRT, high resolution cameras continuously monitor a patient's breathing and position in real-time to create a 3-dimensional map of a patient's skin. The image enables medical care teams to easily visualize the difference between the current body position and the target position, helping to ensure the patient is appropriately positioned when radiation is delivered.
8 MINUTES AGO, 5:30 PM EDT
VIA PR NEWSWIRE
The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments
MADISON, Wis., Sept. 10, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Gifu Prefectural General Medical Center is setting a new standard in cancer care in Japan as the first hospital in the country to treat patients with surface-guided radiation therapy (SGRT) using the company's Radixact® Radiation Delivery System and VitalHold™* package. SGRT is designed to help medical care teams to effectively position the patient and confidently monitor the accuracy of that positioning throughout treatment. The ability to confidently monitor also enables the deep inspiration breath hold (DIBH) technique, which is often used in left breast cancer treatment to help protect the heart from radiation.
During treatment with SGRT, high resolution cameras continuously monitor a patient's breathing and position in real-time to create a 3-dimensional map of a patient's skin. The image enables medical care teams to easily visualize the difference between the current body position and the target position, helping to ensure the patient is appropriately positioned when radiation is delivered.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Sean Parker : hopefully this will pop in the am.
Trytosaveabit OP Sean Parker : Indeed
iAnxiety : this is a good news right?
Trytosaveabit OP iAnxiety : It is good news! Now it’s up to the market to decide if they like it as well! But yes!
iAnxiety Sean Parker : sad no movement
iAnxiety Trytosaveabit OP : sorry but why cant i sell my stock on this?
Trytosaveabit OP iAnxiety : This ticker is not has not had a single sell yet this morning! The spread is really wide right now. No liquidity! So depending on your price? No buyers yet!
iAnxiety : i see, thank you for explaining
Trytosaveabit OP iAnxiety : You’re very welcome! GL![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
iAnxiety : hmmm im stuck here, cant even sell at the current price :(
View more comments...